New Tube-Feeding formula aims to steady blood sugar in diabetics
NCT ID NCT05859165
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This completed study tested whether a diabetes-specific tube-feeding formula (Nutren Diabetes) can control blood sugar as well as another formula (Fresubin Diabetes) in diabetic patients who have trouble swallowing. 233 adults aged 18-90 took part, receiving tube feeding for up to 12 days. The main goal was to compare average blood sugar levels over 24 hours between the two groups.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Nutren Diabetes (a diabetes-specific tube-feeding formula)
What this could lead to
If it works, this could provide a safe and effective nutritional option for diabetic patients who need tube feeding, helping to keep their blood sugar stable.
What could go wrong
This is a small, completed non-inferiority trial, so results may not apply to all patients. The formula is a dietary supplement, not a drug, so benefits are limited to nutritional support.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking Union Medical College hospital
Beijing, China